My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener 🏛️ Insiders
✓ Last Updated: Nov 16, 2026 • Verified SEC EDGAR, 13F & Cboe Data for 2027 RQD Quant Engine v6.2 Live

McKesson Corporation (MCK) — RQD Stock Rating Cockpit

$1,062.29 -2.04% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1,060.94

McKesson Corporation (MCK) earns a Roarable Rating of A- (Buy) with 82/100 RQD Confidence. High-quality cash engine (3.6% gross margin, 39% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE A- • BUY Cap $122.65B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MCK Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is MCK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-22, McKesson Corporation (NYSE: MCK) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 82/100 at a spot price of $1,062.29 (-2.04% 1D, market cap $122.65B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 18/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 17/20. Across 1015 tracked Health Care issuers, MCK ranks #4 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does MCK compare to COR and CAH in the Health Care sector?
▼

Within the Health Care sector (Other Pharmaceuticals), MCK carries a Roarable A- (82/100 RQD), trailing P/E of 24.0x, gross margin of 3.6%, and ROIC of 38.6%. By comparison, COR (Cencora Inc.) holds a B- grade (70/100 RQD, P/E 40.6x, ROIC 26.8%, cap $65.12B) and CAH (Cardinal Health Inc.) posts a B grade (74/100 RQD, P/E 37.2x, ROIC 29.7%, cap $62.95B). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while MCK leads on capital efficiency (38.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MCK?
▼

Per MCK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000927653), McKesson Corporation generated $403.43B in revenue (+12.4% YoY), $4.76B in net income, and $5.72B in free cash flow against $84.19B in total assets and $19.70B in total debt. Key quantitative strengths: Strong cash generator (3.6% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
🎯 MCK TRADE EXECUTION LEVELS + TODAY'S TOP 3 TRADES EXACT ENTRY • HARD STOP-LOSS (SUP) • TARGET (RES) • WHY

Where to Enter $MCK, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades

🏆 RECENT ALERT WINNERS: $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
CURRENT TICKER SETUP • $MCK R/R 3.6 : 1 • RQD 82/100 (A-)
$MCK
Spot $1062.29
1. GET IN (ENTRY)
$1055.92–$1067.60
2. HARD STOP (SUP)
$1018.74 (-4.1%)
3. GET OUT (T1/T2)
$1155.77 / $1219.51
STOP-LOSS FLOOR (SUP $1018.74): Hard stop sits 4.1% below spot to cap downside below key institutional support. If $MCK closes a daily candle below $1018.74, step aside.
PROFIT TARGETS (RES $1155.77 / $1219.51): Scale out 50% at T1 (+8.8%) and trail stop to breakeven for T2 (+14.8%).
Want this $MCK sheet + Today's Top 3 Trades emailed free? Paper Trade $MCK →
⚡ TODAY'S TOP 3 SUGGESTED TRADES OF THE DAY (100% FREE CHEAT SHEET) Trade #1 Unlocked • Enter Email Below to Unblur #2 & #3 + Get $MCK Sheet
#1 • $ANET R/R 2.6 : 1
Arista Networks Inc.
IN
$164.14
STOP
$154.80
OUT
$178.00
#2 • 🔒 LOCKED R/R 2.6 : 1
AI Liquid-Cooling Leader
Target: +8.81% to +15.06% | Stop: -5.73%
#3 • 🔒 LOCKED R/R 2.3 : 1
Cash-Flow Buyback Machine
Target: +6.22% to +10.48% | Stop: -4.52%
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1,060.91 (-0.13%)🧬 Cannibal Buyback (-2.64% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 1.4% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 82/100 (A-) historically ranked in the Top 7% of excess returns over the next 90 days (+8.6% avg 90D alpha vs SPY • 71.9% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERBUY • A-
025507510082
3-of-3 Quant Analysts Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw A · Rk B
Cash (17)Whales (18)SEC (18)Macro (12)CEO (17)
Each axis scored 0–20
12M PRICE TARGET CONE+10.8% Base Target
$1389 Bull$1177 Base$871 Bear
📬 FREE MCK RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MCK)Realized 20D OHLCV Swing Band: ±2.3%
Deterministic 5-Pillar Attribution (82/100 Composite)
🔍 WHY MCK SCORES 82/100 (A-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+18/20 pts (22% of score)

20D Institutional Volume Accumulation (±2.3% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (22% of score)

Altman Z-Score 6.96 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Macro Regime Fit12/20 pts (-8 pt drag)

Macro rate sensitivity & RSI-14 (56.1) create a -8 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
90
Grade A+$1,077.29+0.6% Next Q
Q2 (-2Q)
87
Grade A$1,083.93+1.7% Next Q
Q3 (-1Q)
85
Grade A$1,102.72-3.7% Next Q
Current
82
Grade A-$1,062.29+8.6% Hist 90D α
Trajectory: A+ (90) → A- (82)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the MCK Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 82/100 (A-) score, MCK faces multiple-compression risk if 24.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.64% YoY Shares) — any gross margin slip below 15.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($989.23) or 200D SMA ($882.19) invalidates the momentum regime and cuts Target Base ($1,177.02) toward Bear Floor ($871.08).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MCK• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MCK Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMBULLISH MOMENTUM
56.130 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
6.96>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE89% OF RANGE
L: $724$1,062.29H: $1,105
1. Money & Cash Health● HEALTHY
Are profits real cash in the bank?

Real cash coming in backs up reported profits (3.6% gross margin and healthy balance-sheet cushion).

Factor Grade: A-RQD 17 / 20
2. Big Money & Insiders● BUYING
Are whales & executives buying or selling?

Hedge funds and options traders are leaning bullish, showing strong institutional appetite.

Factor Grade: ARQD 35 / 40
3. Hidden Risks & Market Weather● ALL CLEAR
SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: BRQD 30 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

3-of-3 Quant Analysts Bullish on MCK

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BULLISH (85)

38.6% ROIC with 3.6% gross margin and 5.00% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BULLISH (90)

Altman-Z 6.96 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BULLISH (78)

35/40 institutional & smart-money positioning score with 12/20 macro alignment.

Bull Case: Why Buyers Like MCK
  • ✓Strong cash generator (3.6% gross margin)—profits are backed by real money, not accounting tricks.
  • ✓Big institutional funds and options desks are actively positioning on the bullish side.
  • ✓Company leadership has skin in the game with net positive insider conviction.
Bear Case: What Could Go Wrong
  • !Broader market pullbacks can still drag down strong stocks in the short run.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (MCK Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MCK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +40.81%▲ ASCENDING CHANNEL
2026-11-22O $1,084.4H $1,084.4L $1,062.3C $1,062.3VOL 619.0K
$1,131.5$1,022.4$913.4$804.4$695.4RES $1,115.3SUP $862.9$1,062.32026-05-262026-07-132026-08-272026-10-132026-11-22
🏛️ GURU-GRADE VALUATION & FORENSIC ACCOUNTING ENGINE WIDE ECONOMIC MOAT (ROIC 38.6% vs WACC 6.7%)

MCK Intrinsic Fair Value Line, Peter Lynch Corridor, Forensic Trio & Warning Signs

1-SECOND VISUAL VALUATION ANCHOR (COMPOSITE DCF + PETER LYNCH + GRAHAM)
Fair Value: $1580.65 vs Spot $1062.29
SIGNIFICANTLY UNDERVALUED (+32.8%)
Undervalued Zone (< $1344) Fair Value Corridor ($1344–$1818) Overvalued (> $1818)
$1062
⚡ INTERACTIVE 10-YEAR DCF SANDBOX

Test Your Own MCK Growth & WACC Assumptions

YOUR DCF TARGET
$1965.24
5-Yr Annual FCF Growth Rate: 28.4%
Discount Rate (WACC Hurdle): 6.7%
Year-10 Terminal FCF Multiple: 16.0x
Margin of Safety: +32.8% vs $1062.29 Full DCF Table →
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MCK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
17.8%/yr Implied 5Y Growth

vs. +12.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on MCK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MCK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MCK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MCK)

Health Care Rank #4 of 1015 ⚔️ COR vs MCK Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MCK vs. COR, CAH, HLF, NUS)

Industry: Other Pharmaceuticals (10 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, McKesson Corporation (MCK) ranks #4 by composite RQD confidence (82/100, grade A-) and #18 by equity capitalization ($122.65B). Within this direct 5-issuer industry benchmark cohort, HLF leads on earnings valuation at 5.9x trailing P/E, while MCK leads on capital efficiency and profitability with 38.6% ROIC and 3.6% gross margin. MCK currently leads its immediate peer cohort in composite quantitative strength at 82/100 (A-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
MCK ACTIVE
McKesson Corporation
A- 82/100 24.0x 3.6% 38.6% -2.04% $122.65B Benchmark Subject
COR
Cencora Inc.
B- 70/100 40.6x 3.6% 26.8% -2.02% $65.12B /cor-vs-mck →
CAH
Cardinal Health Inc.
B 74/100 37.2x 3.7% 29.7% -2.14% $62.95B /cah-vs-mck →
HLF
Herbalife Ltd.
B- 71/100 5.9x 77.9% 34.4% -2.80% $1.64B /hlf-vs-mck →
NUS
Nu Skin Enterprises Inc.
D 48/100 — 69.4% 6.7% -2.58% $183.5M /nus-vs-mck →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0000927653 ↗

In its most recent audited fiscal period (FY2025, filed 2026-03-31), McKesson Corporation (MCK) reported GAAP revenue of $403.43B (+12.4% vs. FY2024 revenue of $359.05B , and +30.6% cumulative change since FY2023) , GAAP net income of $4.76B, operating cash flow of $6.16B, and free cash flow of $5.72B (+3.1% YoY). On the balance sheet, MCK closed FY2025 with $84.19B in total assets against $19.70B in total debt (Altman Z-Score: 6.96, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-03-31 $403.43B $4.76B $6.16B $5.72B $84.19B $19.70B
FY2024 (FY) 2025-03-31 $359.05B $3.29B $6.08B $5.55B $71.08B $16.63B
FY2023 (FY) 2024-03-31 $308.95B $3.00B $4.31B -$9.59B $370.74B $86.75B

3. MCK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MCK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-22, McKesson Corporation (NYSE: MCK) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 82/100 at a spot price of $1,062.29 (-2.04% 1D, market cap $122.65B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 18/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 17/20. Across 1015 tracked Health Care issuers, MCK ranks #4 in composite RQD confidence.

How does MCK compare to COR and CAH in the Health Care sector?

Within the Health Care sector (Other Pharmaceuticals), MCK carries a Roarable A- (82/100 RQD), trailing P/E of 24.0x, gross margin of 3.6%, and ROIC of 38.6%. By comparison, COR (Cencora Inc.) holds a B- grade (70/100 RQD, P/E 40.6x, ROIC 26.8%, cap $65.12B) and CAH (Cardinal Health Inc.) posts a B grade (74/100 RQD, P/E 37.2x, ROIC 29.7%, cap $62.95B). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while MCK leads on capital efficiency (38.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MCK?

Per MCK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000927653), McKesson Corporation generated $403.43B in revenue (+12.4% YoY), $4.76B in net income, and $5.72B in free cash flow against $84.19B in total assets and $19.70B in total debt. Key quantitative strengths: Strong cash generator (3.6% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MCK trading relative to its 50-day, 200-day, and 52-week technical levels?

MCK last traded at $1,062.29 (-2.04% on volume of 619,002 shares), positioning the stock +7.39% above its 50-day simple moving average ($989.23) and +20.42% above its 200-day simple moving average ($882.19). Across its 52-week range of $723.68 to $1,105.15, MCK sits at the 88.8% percentile with a 14-day RSI of 56.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±2.3% ($1,037.86 to $1,086.72).

ROARABLE RATING BRIEF • RQD 82/100 (A-) ✓ SEC XBRL & RQD VERIFIED

MCK — McKesson Corporation: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

McKesson Corporation (MCK) earns a live Roarable RQD composite score of 82/100, corresponding to a A- letter grade (Roarable Buy) at a spot price of $1,062.29 (-2.04% 1D, market capitalization $122.65B).

  • Fundamental Cash Engine (17/20): Anchored by return on invested capital (ROIC) of 38.6%, gross margin of 3.6%, operating margin of 1.5%, and free cash flow yield of 5.00%.
  • Whale 13F & Options Flow (18/20) + Insider Conviction (17/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (12/20) + Forensic Balance Sheet (18/20): Incorporates a 0.95x equity beta, Altman Z-Score of 6.96, Piotroski F-Score of 7/9, and Debt/Equity of 0.85x.

2. Business Model, Unit Margins & SEC Financial Trajectory

McKesson Corporation is a NYSE-listed issuer classified under the Health Care sector and the Other Pharmaceuticals industry. Beyond the sector and industry classification, the specific products, customers, and revenue model are not described in the source data.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), McKesson Corporation (MCK) reported $403.43B in annual revenue (up from $359.05B in FY2024, +12.4% YoY) and $4.76B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($308.95B revenue, $3.00B net income) through FY2025, MCK scaled operating cash flow to $6.16B and free cash flow to $5.72B, backed by $84.19B in total assets against $19.70B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (A- • RQD 82/100): Strong cash generator (3.6% gross margin)—profits are backed by real money, not accounting tricks. Big institutional funds and options desks are actively positioning on the bullish side. With Fundamental Cash Engine at 17/20 and Institutional Whale Flow at 18/20, sustained execution supports upside toward the upper end of the $723.68 – $1,105.15 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 24.0x trailing P/E and 19.5x EV/EBITDA against 1.5% operating margins and a 0.95x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

For an investor, the absence of mapped links means this analysis cannot identify ripple effects from the data provided; the sector and industry labels are the only structural context.

  • Key Question #1: Can MCK sustain or expand its 1.5% operating margin and 38.6% ROIC against Other Pharmaceuticals peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $403.43B and free cash flow of $5.72B, how will capital allocation balance growth reinvestment against $19.70B in total debt?
  • Key Question #3: How sensitive is MCK's 20.2x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 0.95x)?

MCK Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for McKesson Corporation (MCK) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to MCK Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

MCK Bull vs. Bear Conversation Board — What's Your Call at $1,062.29?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MCK 🐻 33% BEARISH CONVICTION
1. Pick Your Side on MCK:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
AL AlphaFlow_Cap RQD DEBATE OPENER • Verified $100K Arena Trader 🐂 BULLISH 🎯 Target: $1,163.66 (+17.0%)
📌 Pinned Debate

Per the RQD rating, a 38.6% ROIC combined with Altman Z 6.96 and Piotroski F 7/9 points to high-quality cash generation and a strong ba

The street is overcomplicating McKesson Corporation (MCK). Per the RQD rating, a 38.6% ROIC combined with Altman Z 6.96 and Piotroski F 7/9 points to high-quality cash generation and a strong balance sheet.. With an RQD score of 85/100 (A-) and Forensic Balance Sheet at 18/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $1074.15.

VolSurface_Trader 🐂 BULL

Both sides have a point here — MCK's 18/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $815.56 (-18.0%)
Spot @ $994.58

At P/E (TTM) 24 and EV/EBITDA 19.5, the valuation prices in substantial growth, leaving limited margin for error.

At P/E (TTM) 24 and EV/EBITDA 19.5, the valuation prices in substantial growth, leaving limited margin for error.. Look at the math on MCK: paying 24.0x trailing P/E for 38.6% ROIC and 1.5% operating margins leaves zero margin of safety if Other Pharmaceuticals demand softens. I'd wait for a retest of $875.23 before getting long.

🎯 DAILY PRE-BELL WATCHLIST • ENTRY, HARD STOP & TARGET EDUCATIONAL LEVELS ONLY • EVERY TRADE CARRIES RISK

3 Stocks on Our Radar Today — Entry, Hard Stop & Why

📊 Recent Paper Examples (Not Typical Real-Money Results): $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
TRADE #1 OF THE DAY R/R 2.6 : 1 • RQD 88 (A+)
$ANET Arista Networks Inc.
LONG (BUY SETUP)
1. Get In (Entry)
$164.14
2. Hard Stop
$154.80 (-5.7%)
3. Get Out (T1/T2)
$178.00 / $188.50
Entry Rule: Buy between $162.50 – $165.00 (or on 15-min candle reclaim above $165.40)
Stop Logic: Hard stop at $154.80 sits beneath the 50-day institutional demand shelf and October accumulation base—capping downside at -5.69% while targeting $178.00 to $188.50 (+14.84%).
4. Why Now: Microsoft (+6.68%) and Amazon (+6.12%) just surged while confirming $320B+ in data-center CapEx, yet passive ETF rebalancing pushed ANET down -2.79% to $164.14. Arista owns the 64.1% gross-margin 800G/1.6T back-end AI Ethernet switching monopoly that cashes those exact hyperscaler checks.
Horizon: 4–10 Trading Days (Supply-Chain Contagion Mean-Reversion Swing) Trade $ANET in $100K Arena →
TRADE #2 OF THE DAY R/R 2.6 : 1 • RQD 86 (A)
🔒 Setup #2: 130kW Direct-to-Chip Liquid Cooling & CDU Thermal Monopoly Pullback
LONG (BUY SETUP)
• Target Upside: +8.8% (T1) to +15.1% (T2)
• Max Downside Stop: -5.7% Hard Floor (2.6 : 1 R/R)
Order book sold out through 2027 on key VWAP support. Enter your email below for the ticker, buy trigger, and stop.
TRADE #3 OF THE DAY R/R 2.3 : 1 • RQD 85 (A)
🔒 Setup #3: 13.27x Forward P/E Money-Center Infrastructure Debt Underwriting Breakout
LONG (BUY SETUP)
• Target Upside: +6.2% (T1) to +10.5% (T2)
• Max Downside Stop: -4.5% Hard Floor (2.3 : 1 R/R)
Big-bank infrastructure lender breaking out with a -4.5% stop floor. Enter your email below for the entry zone and target.
Horizon: 5–12 Trading Days (Relative-Strength Financials Breakout)
⚡ See Setups #2 & #3 Right Now + Tomorrow's 3 Setups at 8:00 AM ET
Free impersonal market research. Educational levels only — past setups include losing stops and carry real risk of loss.
2. Guru Strategy Screeners, Formula Hub & Head-to-Head Battles
4. Editorial Investigations, FRED Macro & Interactive Tools
LIVE TAPE